Sign in

CIK 0001817229

  • Emerging growth company

Vor Biopharma Inc.

Sign in to watch
Ticker
VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
811591163
Phone
+1 617-655-6580
Business address
500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
  1. 4 Grant or award Chief Financial Officer acquired 52,500 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy 10% owner bought 38,974,101 shares
  5. 3 Insider Initial Statement of Ownership
  6. 4 Planned sale CHIEF MEDICAL OFFICER sold 10,334 shares at $1.25 ($12,918)
  7. 4 Grant or award Director acquired 16,897,159 shares (grant or award)
  8. 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 875 shares (to pay taxes)
  9. 4 Shares withheld for taxes Vice President of Finance gave up 206 shares (to pay taxes)
  10. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 999 shares (to pay taxes)
  11. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,361 shares (to pay taxes)
  12. 4 Shares withheld for taxes Vice President of Finance gave up 343 shares (to pay taxes)
  13. 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 986 shares (to pay taxes)
  14. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,146 shares (to pay taxes)
  15. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,751 shares (to pay taxes)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 5,576 shares (to pay taxes)
  19. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 12,657 shares (to pay taxes)
  20. 4 Shares withheld for taxes Vice President of Finance gave up 4,951 shares (to pay taxes)

Page 5 of 11 · 212 filings